264 related articles for article (PubMed ID: 35658686)
21. Survival implications vs. complications: unraveling the impact of vitamin D adjunctive use in critically ill patients with COVID-19-A multicenter cohort study.
Al Sulaiman K; Korayem GB; Aljuhani O; Altebainawi AF; Shawaqfeh MS; Alarfaj SJ; Alharbi RA; Ageeli MM; Alissa A; Vishwakarma R; Ibrahim A; Alenazi AA; Alghnam S; Alshehri N; Alshammari MM; Alhubaishi A; Aldhaeefi M; Alamri FF; Syed Y; Khan R; Alalawi M; Alanazi KA; Alresayes FS; Albarqi KJ; Al Ghamdi G
Front Med (Lausanne); 2023; 10():1237903. PubMed ID: 37692775
[TBL] [Abstract][Full Text] [Related]
22. Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients.
Jonmarker S; Hollenberg J; Dahlberg M; Stackelberg O; Litorell J; Everhov ÅH; Järnbert-Pettersson H; Söderberg M; Grip J; Schandl A; Günther M; Cronhjort M
Crit Care; 2020 Nov; 24(1):653. PubMed ID: 33225952
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of zinc sulfate as an adjunctive therapy in COVID-19 critically ill patients: a two center propensity-score matched study.
Al Sulaiman K; Aljuhani O; Al Shaya AI; Kharbosh A; Kensara R; Al Guwairy A; Alharbi A; Algarni R; Al Harbi S; Vishwakarma R; Korayem GB
Crit Care; 2021 Oct; 25(1):363. PubMed ID: 34663411
[TBL] [Abstract][Full Text] [Related]
24. The Role of Inhaled Corticosteroids (ICS) in Critically Ill Patients With COVID-19: A Multicenter, Cohort Study.
Al Sulaiman K; Aljuhani O; Al Aamer K; Al Shaya O; Al Shaya A; Alsaeedi AS; Alhubaishi A; Altebainawi AF; Al Harthi A; Albelwi S; Almutairi R; Alsubaie N; Alsallum A; Korayem GB; Alfahed A; Kensara R; Altebainawi EF; Alenezi RS; Alsulaiman T; Al Enazi H; Vishwakarma R; Al Dabbagh T; Bakhsh U; Al Ghamdi G
J Intensive Care Med; 2022 Feb; 37(2):248-257. PubMed ID: 34757869
[No Abstract] [Full Text] [Related]
25. Incidence and Clinical Outcomes of New-Onset Atrial Fibrillation in Critically lll Patients with COVID-19: A Multicenter Cohort Study - New-Onset Atrial Fibrillation and COVID-19.
Kensara R; Aljuhani O; Korayem GB; Alkofide H; Almohareb SN; Alosaimi YS; Altebainawi AF; Bin Saleh K; Andas NA; Harbi SA; Harthi AFA; Ashkan U; Alghamdi R; Badreldin HA; Hafiz A; AlFaifi M; Alqahtani RA; Vishwakarma R; Alenazi AA; Alalawi M; Mahboob R; Alfouzan RA; Al Tuhayni LB; Qahtani NA; Sulaiman KA
Clin Appl Thromb Hemost; 2023; 29():10760296231156178. PubMed ID: 36789786
[TBL] [Abstract][Full Text] [Related]
26. New Insights in the Occurrence of Venous Thromboembolism in Critically Ill Patients with COVID-19-A Large Postmortem and Clinical Analysis.
Heinrich F; Roedl K; Jarczak D; Goebels HL; Heinemann A; Schäfer U; Ludwig F; Bachmann M; Bein B; Weber CF; Sydow K; Bota M; Paschen HR; de Weerth A; Veit C; Detsch O; Brand PA; Kluge S; Ondruschka B; Wichmann D
Viruses; 2022 Apr; 14(4):. PubMed ID: 35458541
[TBL] [Abstract][Full Text] [Related]
27. Incidence of Venous Thromboembolism and Mortality in Patients with Initial Presentation of COVID-19.
Giannis D; Barish MA; Goldin M; Cohen SL; Kohn N; Gianos E; Chatterjee S; Lesser M; Coppa K; Hirsch JS; McGinn T; Spyropoulos AC;
J Thromb Thrombolysis; 2021 May; 51(4):897-901. PubMed ID: 33665766
[TBL] [Abstract][Full Text] [Related]
28. Association between antecedent statin use and severe disease outcomes in COVID-19: A retrospective study with propensity score matching.
Lohia P; Kapur S; Benjaram S; Mir T
J Clin Lipidol; 2021; 15(3):451-459. PubMed ID: 33726984
[TBL] [Abstract][Full Text] [Related]
29. Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients.
Dujardin RWG; Hilderink BN; Haksteen WE; Middeldorp S; Vlaar APJ; Thachil J; Müller MCA; Juffermans NP
Thromb Res; 2020 Dec; 196():308-312. PubMed ID: 32977128
[TBL] [Abstract][Full Text] [Related]
30. Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action.
Pavoni V; Gianesello L; Pazzi M; Stera C; Meconi T; Frigieri FC
Thromb Res; 2020 Dec; 196():313-317. PubMed ID: 32977129
[TBL] [Abstract][Full Text] [Related]
31. COVID-19: coagulation disorders and anticoagulant treatment in patients hospitalised in ICU.
Pluta J; Cieniewicz A; Trzebicki J
Anaesthesiol Intensive Ther; 2021; 53(2):153-161. PubMed ID: 34006056
[TBL] [Abstract][Full Text] [Related]
32. The impact of protocol-based high-intensity pharmacological thromboprophylaxis on thrombotic events in critically ill COVID-19 patients.
Atallah B; Sadik ZG; Salem N; El Nekidy WS; Almahmeed W; Park WM; Cherfan A; Hamed F; Mallat J
Anaesthesia; 2021 Mar; 76(3):327-335. PubMed ID: 33047335
[TBL] [Abstract][Full Text] [Related]
33. The Impact of Recombinant Human Erythropoietin Administration in Critically ill COVID-19 Patients: A Multicenter Cohort Study.
Al Sulaiman K; Aljuhani O; Korayem GB; Altebainawi AF; Vishwakarma R; AlFaifi M; Alsohimi S; Alrayes A; Albishi S; Alqahtani R; Alalawi M; Al Sulaihim I; Alanazi TA; Alqahtani RA; Almagthali A; Jomah S; Alshlowi A; Alshammari TR; Alzahrani SS; Abdulqader MI
Clin Appl Thromb Hemost; 2023; 29():10760296231218216. PubMed ID: 38073058
[TBL] [Abstract][Full Text] [Related]
34. Clinical features and outcomes of critically ill patients with coronavirus disease 2019 (COVID-19): A multicenter cohort study.
Al Sulaiman KA; Aljuhani O; Eljaaly K; Alharbi AA; Al Shabasy AM; Alsaeedi AS; Al Mutairi M; Badreldin HA; Al Harbi SA; Al Haji HA; Al Zumai OI; Vishwakarma RK; Alkatheri A
Int J Infect Dis; 2021 Apr; 105():180-187. PubMed ID: 33601030
[TBL] [Abstract][Full Text] [Related]
35. An observational study of intermediate- or high-dose thromboprophylaxis for critically ill COVID-19 patients.
Jonmarker S; Litorell J; Dahlberg M; Stackelberg O; Everhov ÅH; Söderberg M; Rubenson-Wahlin R; Günther M; Mårtensson J; Hollenberg J; Joelsson-Alm E; Cronhjort M
Acta Anaesthesiol Scand; 2022 Mar; 66(3):365-374. PubMed ID: 34875111
[TBL] [Abstract][Full Text] [Related]
36. Statin use and venous thromboembolism in cancer: A large, active comparator, propensity score matched cohort study.
El-Refai SM; Black EP; Adams VR; Talbert JC; Brown JD
Thromb Res; 2017 Oct; 158():49-58. PubMed ID: 28822240
[TBL] [Abstract][Full Text] [Related]
37. Postoperative statin therapy is not associated with reduced incidence of venous thromboembolic events following kidney transplantation.
Frasco PE; Rosenfeld DM; Jadlowiec CC; Zhang N; Heilman RL; Bauer IL; Alvord J; Poterack KA
Clin Transplant; 2022 Dec; 36(12):e14805. PubMed ID: 36065684
[TBL] [Abstract][Full Text] [Related]
38. All-cause mortality in COVID-19 patients receiving statin therapy: analysis of veterans affairs database cohort study.
El-Solh AA; Lawson Y; El-Solh DA
Intern Emerg Med; 2022 Apr; 17(3):685-694. PubMed ID: 34637080
[TBL] [Abstract][Full Text] [Related]
39. Association Between Dexamethasone and Delirium in Critically Ill Patients: A Retrospective Cohort Study of a Large Clinical Database.
Wu Z; Li H; Liao K; Wang Y
J Surg Res; 2021 Jul; 263():89-101. PubMed ID: 33639374
[TBL] [Abstract][Full Text] [Related]
40. Early dexamethasone use as a protective measure in non-mechanically ventilated critically ill patients with COVID-19: a multicenter, cohort study.
Al Sulaiman K; Korayem GB; Eljaaly K; Altebainawi AF; Al Harbi O; Badreldin HA; Al Harthi A; Al Yousif G; Vishwakarma R; Albelwi S; Almutairi R; Almousa M; Alghamdi R; Alhubaishi A; Alissa A; Alharbi A; Algarni R; Al Homaid S; Al Qahtani K; Akhani N; Al Atassi A; Al Ghamdi G; Aljuhani O
Sci Rep; 2022 Jun; 12(1):9766. PubMed ID: 35697822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
